share_log

Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence

Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence

Xcelerate, Inc. 聘请领先的投资者关系公司 Darrow Associates 以增强资本市场的影响力
Accesswire ·  03/25 08:30

MAULDIN, SC / ACCESSWIRE / March 25, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has retained Darrow Associates to represent the Company as its investor relations ("IR") advisor. In this capacity, Darrow Associates will support Xcelerate as the primary contact with investors and seek to increase awareness of the Company's growth opportunities with the broader financial community.

南卡罗来纳州莫尔丁/ACCESSWIRE/2024年3月25日/Xcelerate, Inc.(OTCQB: XCRT)今天宣布,它已聘请Darrow Associates代表公司担任其投资者关系(“IR”)顾问。Darrow Associates将以此身份支持Xcelerate作为与投资者的主要联系人,并努力提高更广泛的金融界对公司增长机会的认识。

"We are excited about the new partnership with Darrow Associates as our IR representative," said Mike O'Shea, CEO of Xcelerate. "We have much work ahead of us to enhance our investor communication strategy and effectively relay our exciting story to the investment community. The Darrow Associates team has significant and highly relevant IR experience as well as an outstanding investment community network, which we believe will complement the leadership of Xcelerate as we work together to communicate our value to investors."

Xcelerate首席执行官迈克·奥谢说:“我们对与作为投资者关系代表的Darrow Associates建立新的合作伙伴关系感到兴奋。”“要加强我们的投资者沟通策略并有效地向投资界传达我们的激动人心的故事,我们还有很多工作要做。Darrow Associates团队拥有丰富且高度相关的投资者关系经验以及出色的投资社区网络,我们相信这将补充Xcelerate的领导地位,共同努力向投资者传达我们的价值。”

About Xcelerate, Inc.

关于 Xcelerate, Inc.

Xcelerate is a healthcare services and products company engaged in three separate but related businesses within the medical, health and wellness sectors; 1) Development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through our technology; 2) Formulating, packaging and marketing of clinically tested health and beauty; 3) Owing and or licensing of rights and patents to various forms of medical equipment.

Xcelerate是一家医疗保健服务和产品公司,在医疗、健康和保健领域从事三项独立但相关的业务;1)开发医疗技术和虚拟健康服务,通过我们的技术扩大医生的覆盖范围,帮助发展中国家的患者满足其医疗需求;2)制定、包装和营销经过临床测试的健康和美容产品;3)拥有和/或许可各种形式的医疗设备的权利和专利。

About Darrow Associates

关于达罗协会

Darrow Associates is an investor relations and financial communications firm with coverage throughout the United States. The firm was established in New York in 2005 and since that time has added to its professional staff to become one of the largest and most trusted IR consulting firms for middle market companies. Darrow Associates professionals have significant experience in partnering with public and pre-IPO companies in the technology, media and telecommunications (TMT), business services, alternative energy, clean technology, healthcare/medtech, financial services, industrial, and aerospace and defense industries. Additional information is available at .

Darrow Associates是一家投资者关系和金融传播公司,业务覆盖美国各地。该公司于2005年在纽约成立,此后增加了专业人员,成为中间市场公司规模最大、最值得信赖的投资者关系咨询公司之一。Darrow Associates的专业人员在与科技、媒体和电信(TMT)、商业服务、替代能源、清洁技术、医疗保健/医疗技术、金融服务、工业以及航空航天和国防行业的上市公司和上市前公司合作方面拥有丰富的经验。其他信息可在以下网址获得。

SAFE HARBOR

安全港

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.

本新闻稿可能包含经修订的1934年《证券交易法》(“交易法”)第21E条所指的前瞻性信息,包括所有非历史事实陈述的陈述,这些陈述涉及公司、其董事或高级管理人员在以下方面的意图、信念或当前期望:(i)公司的融资计划;(ii)影响公司财务状况或经营业绩的趋势;(iii)公司的增长战略和运营战略;以及 (iv)股息的申报和支付。“可能”、“会”、“将”、“期望”、“估计”、“预期”、“相信”、“打算” 等词以及类似的表述和变体旨在识别前瞻性陈述。投资者请注意,任何此类前瞻性陈述都不能保证未来的表现,并涉及风险和不确定性,其中许多风险和不确定性超出了公司的控制能力,实际业绩可能与前瞻性陈述中的预测存在重大差异 由于 各种因素。

Contacts

联系人

Investors:
Matt Kreps
214-597-8200
mkreps@darrowir.com

投资者:
马特·克雷普斯
214-597-8200
mkreps@darrowir.com

SOURCE: Xcelerate, Inc.

资料来源:Xcelerate, Inc.


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发